Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts

N/AActive Not RecruitingNCT02664701

Centre Hospitalier Universitaire de Nīmes240 enrolled

Overview

The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.

The secondary objectives of this study are to assess the efficacy of CBGT on: A. parameters describing the incidence of suicide and repeat suicide attempts, as well as suicide re-attempt free follow-up time, B. long-term changes in suicidal ideation, C. long-term changes in psychiatric symptoms (depression, hope for the future, hospitalization).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

240

Conditions

Suicidal Ideation Suicide, Attempt

Interventions

Baseline evaluation with a psychiatristOTHER

Baseline data and questionnaires are established.

Individual supportive therapyOTHER

6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks

Cognitive behavioural group therapyOTHER

6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The patient has been correctly informed * The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * French speaking adults (18 years or older) freely hospitalized (in centres or via emergency services) for prevention of suicide and who have a medium or high suicide risk score according to a Mini International Neuropsychiatric Interview structured interview * Presence of suicidal ideation according to the Beck Suicide Ideation Scale (score \> 3) * Prior (or recent) suicide attempt within the last three month * The patient is able to understand the study and capable of giving his/her informed consent * The patient is available during the weekly time slots proposed by the investigator Exclusion Criteria: * The patient is participating in another study that may interfere with the results or conclusions of this study * Within the past three months, the patient has participated in another study that may interfere with the results or conclusions of this study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, or is an adult under guardianship * The patient refuses to sign the consent, or it is impossible to correctly inform the patient * Emergency situations preventing proper study conduct * History of schizophrenia or other psychotic troubles * Presence of psychotic symptoms at initial interview * Serious cognitive impairment * Medical incapacity to participate

Locations (9)

CHU de Clermont Ferrand - Hôpital Gabriel-Montpied

Clermont-Ferrand, France

CHU de Lyon - Groupement Hospitalier Edouard Herriot

Lyon, France

CHRU de Montpellier - Hôpital Lapeyronie

Montpellier, France

Clinique Les Sophoras

Nîmes, France

Outcomes

Primary Outcomes

The primary clinical endpoint is the duration (in days) of a suicide reattempt-free follow-up period

Time frame: 12 months